ES2065908T3 - Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii". - Google Patents

Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".

Info

Publication number
ES2065908T3
ES2065908T3 ES88302521T ES88302521T ES2065908T3 ES 2065908 T3 ES2065908 T3 ES 2065908T3 ES 88302521 T ES88302521 T ES 88302521T ES 88302521 T ES88302521 T ES 88302521T ES 2065908 T3 ES2065908 T3 ES 2065908T3
Authority
ES
Spain
Prior art keywords
prophylaxis
treatment
composition
pneumonia
pneumocystis carinii
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88302521T
Other languages
English (en)
Inventor
Edward M Bernard
Donald Armstrong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Sloan Kettering Institute for Cancer Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sloan Kettering Institute for Cancer Research filed Critical Sloan Kettering Institute for Cancer Research
Application granted granted Critical
Publication of ES2065908T3 publication Critical patent/ES2065908T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Otolaryngology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)

Abstract

SE DESCRIBE UNA COMPOSICION PARA LA PROFILAXIS O EL TRATAMIENTO DE LA NEUMONIA POR PNEUMOCYSTIS CARINII QUE CONSISTE EN UNA PULVERIZACION AEROSOL DE PENTAMIDA O UNA SAL FARMACOLOGICAMENTE ACEPTABLE DE LA MISMA, LA CUAL CONTIENE CANTIDADES IMPORTANTES DE PARTICULAS QUE TIENEN UN DIAMETRO AERODINAMICO EN LA GAMA DE 0,5 A 8,0 MICRAS.
ES88302521T 1987-03-26 1988-03-23 Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii". Expired - Lifetime ES2065908T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3087387A 1987-03-26 1987-03-26
US16256288A 1988-03-01 1988-03-01

Publications (1)

Publication Number Publication Date
ES2065908T3 true ES2065908T3 (es) 1995-03-01

Family

ID=26706546

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88302521T Expired - Lifetime ES2065908T3 (es) 1987-03-26 1988-03-23 Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".

Country Status (10)

Country Link
EP (1) EP0292100B1 (es)
JP (1) JPH01228912A (es)
AT (1) ATE116847T1 (es)
AU (1) AU620025B2 (es)
CA (1) CA1334577C (es)
DE (1) DE3852717T2 (es)
DK (1) DK164788A (es)
ES (1) ES2065908T3 (es)
GR (1) GR3015412T3 (es)
IE (1) IE66819B1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE77947T1 (de) * 1987-04-09 1992-07-15 Fisons Plc Pentamidin enthaltende pharmazeutische zusammensetzungen.
US5204113A (en) * 1987-04-09 1993-04-20 Fisons Plc Pharmaceutical compositions containing pentamidine
IN168530B (es) * 1987-11-06 1991-04-20 Lyphomed Inc
US5366726A (en) * 1987-12-23 1994-11-22 The Regents Of The University Of California Suppression of Pneumocystis carinii using aerosolized pentamidine treatment
US4853416A (en) * 1988-04-25 1989-08-01 Fisons Corporation Solutions of pentamidine
GB8903438D0 (en) * 1989-02-15 1989-04-05 May & Baker Ltd New compositions of matter
ATE223202T1 (de) * 1994-09-30 2002-09-15 Mika Pharma Ges Fuer Die Entwi Pharmazeutische zusammensetzung

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3533494A1 (de) * 1985-09-17 1987-03-19 Meyer Glauner Wilhelm Dr Aerosol-anwendung von pentamidin (p,p'-(pentamethylen-dioxy)-dibenzamidin-bis(ss-hydroxyethansulfonat) zur behandlung der durch pneumocystis carinii bedingten lungenentzuendung

Also Published As

Publication number Publication date
EP0292100A1 (en) 1988-11-23
DE3852717T2 (de) 1995-05-18
AU620025B2 (en) 1992-02-13
DK164788A (da) 1988-09-27
EP0292100B1 (en) 1995-01-11
IE880913L (en) 1988-09-26
GR3015412T3 (en) 1995-06-30
JPH01228912A (ja) 1989-09-12
CA1334577C (en) 1995-02-28
IE66819B1 (en) 1996-02-07
DK164788D0 (da) 1988-03-25
DE3852717D1 (de) 1995-02-23
ATE116847T1 (de) 1995-01-15
AU1331788A (en) 1988-09-29

Similar Documents

Publication Publication Date Title
DK360489D0 (da) Produkter indeholdende mikro- eller nanopartikler samt fremgangsmaade til deres fremstilling
IT1111881B (it) Procedimento e dispositivo per la depurazione dell'aria di scarico di cabine di spruzzatura
FR2601876B1 (fr) Composition pharmaceutique hydrosoluble contenant de la n-acetyl-cysteine et de l'acide citrique
ATE77947T1 (de) Pentamidin enthaltende pharmazeutische zusammensetzungen.
MX18106A (es) Compuesto amidinicos y composiciones usadas para el tratamiento de pneumonia por pneumocystis carinii y otras enfermedades.
ES2065908T3 (es) Composicion para la profilaxis y tratamiento de neumonia por "pneumocystis carinii".
ATE137958T1 (de) Pharmazeutische aerosolzubereitung sowie deren verwendung zur behandlung und prophylaxe viraler erkrankungen
FI946203A (fi) Absorboiva hienojakoinen hydrogeelimateriaali absorboivissa rakenteissa
AU2447688A (en) Pentamidine salts useful in the treatment and prophylaxis of pneumocystis carinii pneumonia
AU626033B2 (en) Methods for the treatment and prophylaxis of pneumocystis carinii pneumonia and other diseases and compounds and formulations for use in said methods
DE3682862D1 (de) Aerosolmittel zur nasenverstaeubung von vitamin b 12.
ATE120730T1 (de) 3.3'-dithiobis (propionsäuren) und estern davon.
ES2055178T3 (es) Composiciones de gemfibrozil dispersables en agua.
IT1175398B (it) Procedimento ed impianto per la liberazione da polveri cioe' depolverazione di particelle, per la depolverazione di particelle di allumina ed altro
FR2644038B1 (fr) Prevention de la contamination par aflatoxine des cereales et des noix par application d'iturine
DE3482027D1 (de) Deodorantmittel.
EP0293342A3 (en) Apparatus preventing the return of atomized spray into dental surgery instruments having seperate air and water lines
IT9021002A0 (it) Agente per la prevenzione ed il trattamento dell'opacita' del cristallino
DK419789D0 (da) Farmaceutisk praeparat
IT1200460B (it) Composizioni di farmaci dotae di attivita' antimicrobica e procedimento per la loro preparazione
IT1224184B (it) Procedimento per la formazione di giunzioni nelle camere d'aria di natanti pneumatici e per altri impieghi
IT8746303A0 (it) Impiego di aria compressa come propellente innocuo per l'uomo eper l'ambiente nelle bombolette spray

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 292100

Country of ref document: ES